Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This Phase 2 study will be a multicenter, double-blind, randomized, active-comparator study
to evaluate the safety and efficacy of tranilast in combination with allopurinol in patients
with hyperuricemia and moderate to severe gout.